Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Total Non-Current Liabilities (2020 - 2021)

Rani Therapeutics Holdings (RANI) has 1 years of Total Non-Current Liabilities data on record, last reported at $8.0 million in Q4 2020.

  • For Q4 2020, Total Non-Current Liabilities changed N/A year-over-year to $8.0 million; the TTM value through Dec 2020 reached $8.0 million, changed N/A, while the annual FY2020 figure was $8.0 million, N/A changed from the prior year.
  • Total Non-Current Liabilities reached $8.0 million in Q4 2020 per RANI's latest filing.
  • Across five years, Total Non-Current Liabilities topped out at $8.0 million in Q4 2020 and bottomed at $8.0 million in Q4 2020.